Exchange Announces Preliminary Designation of Jeonjin Bio Pharm as a Non-Compliant Disclosure Corporation Due to Disclosure Failures...
The Korea Exchange KOSDAQ Market Division announced on the 11th that it has given advance notice of designation as an unfaithful disclosure corporation to Jeonjin Bio Pharm due to failure to disclose and reversal of disclosure.
The deadline for the decision is the 5th of next month.
Hot Picks Today
"After Being Promoted to Director-General, My Salary Dropped by Over 10 Million Won"...Japanese Workers Shun Promotion
- "Monthly Salary of 1.77 Million Won? Over 700 Applicants Flock to Unexpected Job"
- "Using Mom and Dad's Card for Living Expenses"... Following Tax-Saving Tips May Land You with the National Tax Service
- "Don't Start with a Shower"... Unexpected Body Areas That Cool You Down Fast During a Heatwave
- No Broth, Smaller Portions, So “Just One Pack”—But Surprise: The Hidden Truth of Bibim Ramen [Matjalal X-File]
The details include 5 cases of disclosure reversal and 1 case of failure to disclose.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
